Biomerica, Inc.
BMRA
$0.604
-$0.009-1.47%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.64M | 1.81M | 1.12M | 1.02M | 1.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.64M | 1.81M | 1.12M | 1.02M | 1.57M |
| Cost of Revenue | 1.20M | 1.52M | 1.10M | 1.17M | 1.24M |
| Gross Profit | 437.00K | 289.00K | 20.00K | -149.00K | 325.00K |
| SG&A Expenses | 1.17M | 1.36M | 1.28M | 1.51M | 1.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.63M | 3.18M | 2.64M | 3.02M | 3.18M |
| Operating Income | -993.00K | -1.37M | -1.53M | -2.00M | -1.61M |
| Income Before Tax | -953.00K | -1.31M | -1.41M | -1.91M | -1.50M |
| Income Tax Expenses | -3.00K | 4.00K | 7.00K | 4.00K | 8.00K |
| Earnings from Continuing Operations | -950.00K | -1.32M | -1.42M | -1.92M | -1.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -950.00K | -1.32M | -1.42M | -1.92M | -1.51M |
| EBIT | -993.00K | -1.37M | -1.53M | -2.00M | -1.61M |
| EBITDA | -971.00K | -1.35M | -1.51M | -1.98M | -1.59M |
| EPS Basic | -0.06 | -0.08 | -0.08 | -0.11 | -0.09 |
| Normalized Basic EPS | -0.03 | -0.05 | -0.05 | -0.07 | -0.06 |
| EPS Diluted | -0.06 | -0.08 | -0.09 | -0.11 | -0.09 |
| Normalized Diluted EPS | -0.03 | -0.05 | -0.05 | -0.07 | -0.06 |
| Average Basic Shares Outstanding | 17.12M | 16.82M | 16.82M | 16.82M | 16.82M |
| Average Diluted Shares Outstanding | 17.12M | 16.82M | 16.82M | 16.82M | 16.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
